Vivek Durai
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immune Response and Inflammation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 16
- T-cell and B-cell Immunology 13
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 8
- Immune Response and Inflammation 2
-
- RNA Interference and Gene Delivery 2
- Co-authors
- Kenneth M. Murphy (20 shared papers)Carlos G. Briseño (13 shared papers)Theresa L. Murphy (6 shared papers)Xiaodi Wu (7 shared papers)Prachi Bagadia (10 shared papers)Arifumi Iwata (6 shared papers)Gary E. Grajales‐Reyes (6 shared papers)Nicole M. Kretzer (6 shared papers)
- Journals
- Nature Immunology (3 papers)The Journal of Experimental Medicine (3 papers)Proceedings of the National Academy of Sciences (2 papers)Nature (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Vivek Durai
23 papers receiving 2.7k citations
Vivek Durai's Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology 1.9k
- Oncology 599
- Biological Psychiatry 30
- Molecular Biology 638
- Immunology and Allergy 50
Countries citing papers authored by Vivek Durai
This map shows the geographic impact of Vivek Durai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Durai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Durai more than expected).
Fields of papers citing papers by Vivek Durai
This network shows the impact of papers produced by Vivek Durai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Durai. The network helps show where Vivek Durai may publish in the future.
Co-authors
The 25 scholars most cited alongside Vivek Durai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity Hit paper breakdown → | 2020 | 380 |
| 2 | 2016 | 351 | |
| 3 | 2016 | 300 | |
| 4 | 2012 | 289 | |
| 5 | 2015 | 280 | |
| 6 | 2018 | 234 | |
| 7 | 2016 | 155 | |
| 8 | 2016 | 93 | |
| 9 | 2017 | 92 | |
| 10 | 2019 | 82 | |
| 11 | 2016 | 64 | |
| 12 | 2014 | 63 | |
| 13 | 2018 | 62 | |
| 14 | 2018 | 49 | |
| 15 | 2010 | 48 | |
| 16 | 2021 | 37 | |
| 17 | 2017 | 30 | |
| 18 | 2022 | 26 | |
| 19 | 2021 | 25 | |
| 20 | 2018 | 9 |
About Vivek Durai
Vivek Durai is a scholar working on Immunology, Molecular Biology, Surgery, Oncology and Genetics, having authored 23 papers that have together received 2.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (13 papers), Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (8 papers), RNA Interference and Gene Delivery (2 papers), CAR-T cell therapy research (2 papers), Immune Response and Inflammation (2 papers), Virus-based gene therapy research (2 papers) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Immunology (1.9k citations), Oncology (599 citations), Biological Psychiatry (30 citations), Molecular Biology (638 citations) and Immunology and Allergy (50 citations). Vivek Durai has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Kenneth M. Murphy, Carlos G. Briseño, Theresa L. Murphy, Xiaodi Wu, Prachi Bagadia, Arifumi Iwata, Gary E. Grajales‐Reyes, Nicole M. Kretzer, Roxane Tussiwand and Derek J. Theisen. Their work appears in journals such as Nature Immunology, The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, Nature and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.